e-learning
resources
London 2016
Tuesday, 06.09.2016
Orphan diseases II
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Computed tomography patterns in patients with cytotoxic drug-induced pulmonary toxicity
Hiroki Umezawa (Chiba, Japan), Hiroki Umezawa, Yusuke Naito, Jiro Terada, Kenji Tsushima, Koichiro Tatsumi
Source:
International Congress 2016 – Orphan diseases II
Session:
Orphan diseases II
Session type:
Thematic Poster
Number:
3924
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Hiroki Umezawa (Chiba, Japan), Hiroki Umezawa, Yusuke Naito, Jiro Terada, Kenji Tsushima, Koichiro Tatsumi. Computed tomography patterns in patients with cytotoxic drug-induced pulmonary toxicity. Eur Respir J 2016; 48: Suppl. 60, 3924
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Imaging of complicated pneumonia: what is new?
Related content which might interest you:
Incidental findings on PET-CT scans; how they are managed and how they impact on the lung cancer pathway
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014
Lung cancer risk based on visual assessment of emphysema and interstitial abnormalities in low dose chest CT
Source: International Congress 2014 – Different modalities and techniques for lung imaging
Year: 2014
Association with emphysema on computed tomography and lung cancer in smokers
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Cytology and chest computed tomography findings of pleural effusion in patients with lung cancer
Source: International Congress 2015 – Interventional pulmonology for pleural diseases
Year: 2015
Lung cancer revisited – CT scan and bronchoscopy concordance after treatment
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016
The effect of positron emission tomography (PET-CT) on the management of patients with non-small cell lung cancer (NSCLC) prior to oncological treatment
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Tuberculosis in patients with different lung neoplasm: The analysis of 17126 patients. MDCT with perfusion, virtual bronchoscopy and pulmonary angiography
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013
Clinical profile and survival of patients undergoing surgery for non-small cell lung cancer: Impact of positron emission tomography adoption
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Comparison between dual-energy computed tomography and standard lung perfusion scintigraphy in preoperative evaluation of lung cancer patients
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013
The utility of fluorodeoxyglucose positron emission tomographyin the evaluation of carcinoid tumors presenting as pulmonary nodules. Experience in our hospital
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Pneumothoraces in CT guided lung biopsies – Are we too cautious?
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016
Should CT-guided biopsy for suspected lung cancer be delayed pending PET/CT results?
Source: International Congress 2016 – Transbronchial diagnostics: from ILD to pheripheral lesions
Year: 2016
The role of octreotate scan in discrimination of solitary pulmonary nodule
Source: Annual Congress 2013 –Structural and functional imaging discussion: sometimes different but always linked
Year: 2013
Body composition analysis using computed tomography image in patients with advanced lung cancer
Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations
Year: 2013
Should bronchoscopy be performed in all patients with haemoptysis and a normal CT chest?
Source: International Congress 2014 – Diagnosis, imaging and surgery for thoracic tumours
Year: 2014
Ultrasound in the assessment of interstitial lung diseases: Correlation with high-resolution computed tomography and lung functions
Source: International Congress 2015 – Interstitial lung diseases II
Year: 2015
Density gradient of the lung parenchyma at computed tomography in patients with pulmonary hypertension
Source: International Congress 2014 – ILDs 3
Year: 2014
Can computed tomography characteristics predict outcomes in patients undergoing radial EBUS-guided biopsy of peripheral lung lesions?
Source: International Congress 2014 – Bronchoscopy in peripheral pulmonary lesions and diffuse lung diseases
Year: 2014
Contrast-enhanced CT for detecting pleural malignancy at a large district general hospital
Source: International Congress 2015 – A morphological view of chest pathology
Year: 2015
Computed tomographic screening for lung cancer: individualising the benefit of the screening
Source: Eur Respir J 2007; 30: 843-847
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept